Method and apparatus to monitor patients and treat with intraosseous fluids
View Patent ↗Automatic external defibrillator apparatus may be provided for use in cooperation with an intraosseous apparatus. Apparatus and methods may also be provided to execute protocols calling for external defibrillation and drug delivery. The disclosure provides a medical apparatus including two electrodes, a processor, a display, a driver, a drug delivery slot, a drug delivery port, and a voltage source. The two electrodes may include an attachment operable to releasably connect the two electrodes to the patient. The processor may be operable to collect and analyze a rhythm associated with the patient's heart from the two electrodes. The display may be operable to communicate instructions to a user. The driver may be operable to insert an intraosseous device into a bone and associated bone marrow of the patient. The drug delivery slot may be operable to receive a drug. The drug delivery port may be operable to communicate the drug from the drug delivery slot to the patient via the intraosseous device. The voltage source may be operable to deliver an electric shock to the patient via the two electrodes.
1. Medical apparatus for treating a patient comprising:
two electrodes, the two electrodes including an attachment operable to releasably connect the two electrodes to the patient;
a processor operable to collect and analyze a rhythm associated with the patient's heart from the two electrodes;
a display operable to communicate instructions to a user;
an intraosseous device and a driver operable to insert the intraosseous device into a bone and associated bone marrow of the patient;
a drug delivery slot having at least one dose of a drug disposed therein;
a drug delivery port operable to communicate the drug from the drug delivery slot to the patient via the intraosseous device; and
a voltage source operable to deliver an electric shock to the patient via the two electrodes; and
a housing configured to house the processor, the display, the drug delivery slot, the drug delivery port and the voltage source.
2. The medical apparatus of claim 1 further comprising:
the processor operable to analyze the rhythm based on the Advanced Cardiac Life Support protocol; and
the drug delivery port operable to communicate the drug as prescribed based on the Advanced Cardiac Life Support protocol.
3. The medical apparatus of claim 1 further comprising a rechargeable power supply operable to energize the processor, the display, and the voltage source.
4. The medical apparatus of claim 1 wherein the driver comprises a battery power supply.
5. The medical apparatus of claim 1 comprising the processor operable to activate the voltage source.
6. The medical apparatus of claim 1 wherein the housing further comprises a cradle configured to releasably hold the driver.
7. The medical apparatus of claim 1 wherein the housing further comprises one or more storage slots configured to releasably hold a drug container.
8. The medical apparatus of claim 1 further comprising:
the driver including a rechargeable power supply; and
the housing including a charger operable to supply power to the rechargeable power supply.
9. The medical apparatus of claim 1 further comprising the drug delivery slot operable to receive a drug cartridge comprising at least two single unit dose chambers.
10. The medical apparatus of claim 9 further comprising the drug delivery slot operable to receive a drug cartridge comprising at least two single unit dose chambers surrounding a central axis.
11. Medical apparatus for treatment of a patient, the apparatus comprising:
an intraosseous device operable to penetrate a bone and associated bone marrow;
a cartridge including multiple chambers operable to hold a single dose of one or more drugs;
a drug delivery port operable to communicate the one or more drugs from the multiple chambers in the cartridge to the patient via the intraosseous device;
a processor operable to collect and analyze a rhythm associated with the patient's heart;
a display operable to communicate one or more instructions to a user in relation to treatment of the patient;
a voltage source operable to deliver a defibrillating shock to the patient; and
one or more instructions with directions to administer the one or more drugs to the patient via the intraosseous device.
12. The apparatus of claim 11 further comprising two electrodes operable to communicate the rhythm to the processor.
13. The apparatus of claim 11 further comprising the processor operable to activate the voltage source.
14. The apparatus of claim 11 wherein the one or more instructions include elements of Advanced Cardiac Life Support protocol.
15. The apparatus of claim 11 wherein:
the cartridge comprises a cylindrical drug cartridge having a longitudinal axis and at least two single unit dose chambers disposed generally parallel to the longitudinal axis such that each single unit dose chamber may be accessed by rotating the cartridge around the longitudinal axis; and
each unit dose chamber is operable to communicate with the intraosseous device via the drug delivery port after the unit dose chamber has been accessed by rotating the cartridge.
16. The apparatus of claim 15 further comprising at least six single unit dose chambers disposed generally parallel to the longitudinal axis.
17. A method for treating a patient comprising:
disposing two electrodes on the chest of the patient;
activating an apparatus operable to collect and analyze a rhythm associated with the patient's heart;
receiving one or more instructions from the apparatus;
inserting an intraosseous device into the patient's vascular system in response to the one or more instructions;
automatically, without user interaction, administering a drug to the patient via the intraosseous device in response to the one or more instructions; and
administering a defibrillating shock to the patient in response to the one or more instructions.
18. The method of claim 17 wherein the apparatus provides the one or more instructions based on Advanced Cardiac Life Support protocol.
19. The method of claim 17 wherein the apparatus comprises a voltage source operable to administer the defibrillating shock via the two electrodes.
20. The method of claim 17 wherein the method further comprises connecting the intraosseous device to a drug delivery port associated with the apparatus.
21. The method of claim 17 wherein the method further comprises administering a defibrillating shock to the patient after administering a drug to the patient.